Detalles de la búsqueda
1.
Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AMN002 study.
Haematologica
; 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235519
2.
Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Intern Med J
; 53(4): 599-609, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36441109
3.
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
Br J Haematol
; 198(5): 830-837, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35818641
4.
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia.
Intern Med J
; 51(10): 1707-1712, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664367
5.
Patients with multiple myeloma over a large catchment of 2.5 million square kilometres: a Western Australia retrospective survival review.
Intern Med J
; 50(7): 869-872, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656980
6.
'It is a journey of discovery': living with myeloma.
Support Care Cancer
; 27(7): 2435-2442, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30368672
7.
The second revision of the International Staging System (R2-ISS) stratifies progression-free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population.
Br J Haematol
; 200(2): e17-e21, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36321478
8.
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.
Am J Hematol
; 98(1): E15-E19, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35604280
9.
Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.
Intern Med J
; 48(2): 210-220, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29415351
10.
Bisphosphonate guidelines for treatment and prevention of myeloma bone disease.
Intern Med J
; 47(8): 938-951, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28782211
11.
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Intern Med J
; 47(1): 35-49, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28076910
12.
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration.
Am J Hematol
; 91(9): 894-9, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27222367
13.
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry.
BMC Med Res Methodol
; 16(1): 151, 2016 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27829380
14.
The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.
Am J Hematol
; 90(5): E86-91, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25651830
15.
Automated digital enumeration of plasma cells in bone marrow trephine biopsies of multiple myeloma.
J Clin Pathol
; 75(1): 50-57, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33234694
16.
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.
Value Health
; 14(5): 672-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21839405
17.
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR).
Bone Marrow Transplant
; 56(10): 2533-2543, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34011965
18.
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.
Bone Marrow Transplant
; 56(9): 2152-2159, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33911199
19.
Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis.
J Clin Oncol
; 38(28): 3252-3260, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32730181
20.
Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
Liver Transpl
; 15(4): 421-6, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19326415